A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic Health

Registry ID
NCT07765394
Source registry
NCT
Status
COMPLETED
Phase
NA
Study type
INTERVENTIONAL
Sponsor
Love Wellness
Enrollment
40
Start date
2025-04-07
Completion date
2025-07-28
Last update
2026-08-14

Conditions

Summary

This study evaluates the effects of the Love Wellness supplement Hello Burn Activate on supporting metabolic health in adult females. The 12-week, single-arm, open-label, virtual trial will enroll 40 female participants aged 25-45 who are experiencing challenges with healthy weight management and body confidence. All participants will take one capsule of the test product daily in the morning with their first meal. Participants will complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12 to assess changes in perceived metabolic health, body confidence, overall health, and well-being.

Interventions

Inclusion criteria

Inclusion Criteria: * Be female. * Be aged 25-45. * Currently experiencing issues regarding healthy weight management. * Currently experiencing issues regarding body confidence. * Currently experiencing difficulty maintaining a weight management routine. * Generally healthy - does not live with any uncontrolled chronic disease. * Willing to refrain from taking any products, prescription medications, or supplements that target metabolic health during the test period. * Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study. * Resides in the United States.

Exclusion criteria

Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period. * Anyone taking a prescription GLP-1 medication, including but not limited to Ozempic, Wegovy, or Mounjaro. * Anyone taking a prescription anticoagulant ('blood thinner') medication. * Anyone taking a prescription antibiotic. * Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men). * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period). * Anyone participating in another research study within the next 12 weeks. * Anyone unwilling to follow the study protocol. * Anyone with any allergies or sensitivities to any of the study product ingredients.

Primary outcomes

[{"measure":"Change in Perceived Metabolic Health","timeFrame":"Baseline, Week 4, Week 8, and Week 12"}]

Locations

Related clinical trials

View on source registry